Is it worth screening for vancomycin-resistant Enterococcus faecium colonization?: Financial burden of screening in a developing country.

[1]  H. Apa,et al.  Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci , 2014, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[2]  Mark A. Miller,et al.  Evaluation of Vancomycin-Resistant Enterococci (VRE)–Associated Morbidity Following Relaxation of VRE Screening and Isolation Precautions in a Tertiary Care Hospital , 2014, Infection Control & Hospital Epidemiology.

[3]  H. Green,et al.  Economic analysis of vancomycin-resistant enterococci at a Canadian hospital: assessing attributable cost and length of stay. , 2013, The Journal of hospital infection.

[4]  R. Selvarangan,et al.  Utility of a focused vancomycin-resistant enterococci screening protocol to identify colonization in hospitalized children. , 2012, American journal of infection control.

[5]  A. Karimi,et al.  Epidemiology of vancomycin-resistant enterococci in children with acute lymphoblastic leukemia at two referral centers in Tehran, Iran: a descriptive study. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[6]  K. Carroll,et al.  Targeted Surveillance to Identify Children Colonized with Vancomycin-Resistant Enterococcus in the Pediatric Intensive Care Unit , 2010, Infection Control & Hospital Epidemiology.

[7]  Joseph Finkelstein,et al.  Identifying groups at high risk for carriage of antibiotic-resistant bacteria. , 2006, Archives of internal medicine.

[8]  M. Klein,et al.  Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  P. Bradford,et al.  Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002. , 2004, International journal of antimicrobial agents.

[10]  Carlene A. Muto,et al.  Cost-Effectiveness of Perirectal Surveillance Cultures for Controlling Vancomycin-Resistant Enterococcus , 2002, Infection Control & Hospital Epidemiology.

[11]  G. Eliopoulos,et al.  Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance". , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  F. Schaefer,et al.  Prevalence of vancomycin-resistant enterococci among children with end-stage renal failure. Mid-European Pediatric Peritoneal Dialysis Study Group. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.